SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -87.5% | 11 | -88.9% | 0.00% | – |
| Q1 2022 | $8,000 | -11.1% | 99 | 0.0% | 0.00% | – |
| Q4 2021 | $9,000 | 0.0% | 99 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | +12.5% | 99 | -4.8% | 0.00% | – |
| Q2 2021 | $8,000 | 0.0% | 104 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | +300.0% | 104 | +1385.7% | 0.00% | – |
| Q4 2020 | $2,000 | -66.7% | 7 | -82.9% | 0.00% | – |
| Q3 2020 | $6,000 | -100.0% | 41 | -100.0% | 0.00% | -100.0% |
| Q2 2020 | $38,658,000 | +63.9% | 241,103 | +0.0% | 0.12% | +28.4% |
| Q1 2020 | $23,584,000 | -24.2% | 241,096 | 0.0% | 0.10% | -5.9% |
| Q4 2019 | $31,111,000 | -6.4% | 241,096 | +10.3% | 0.10% | -9.8% |
| Q2 2019 | $33,223,000 | +474514.3% | 218,644 | +383486.0% | 0.11% | – |
| Q1 2019 | $7,000 | -96.2% | 57 | -96.6% | 0.00% | -100.0% |
| Q4 2018 | $183,000 | +4475.0% | 1,666 | +7143.5% | 0.00% | – |
| Q3 2018 | $4,000 | -92.9% | 23 | -97.7% | 0.00% | – |
| Q4 2017 | $56,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |